{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:26:12Z","timestamp":1783506372761,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Topical eye drops are rapidly cleared from the tear film, limiting drug efficacy. We developed a thermosensitive in situ\u2013gelling chitosan\u2013hyaluronic acid (CH\u2013HA) hydrogel for sustained levofloxacin delivery and evaluated its effects in a rabbit corneal chemical-burn model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A chitosan\/\u03b2-glycerophosphate\/HA solution was optimized for sol\u2013gel transition at physiological temperature. Physicochemical properties, in vitro release, cytocompatibility (human MSCs), and antibacterial activity were assessed. Rabbits (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916) with corneal burns received levofloxacin drops (control) or hydrogels twice daily for 5 days. On day-10, corneal oxidative stress markers (TOC, TAC, OSI), semi-quantitative histology, and quantitative epithelial thickness were examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The optimized formulation (30% \u03b2-glycerophosphate) gelled within ~\u200915 min at 37 \u00b0C and displayed a porous, biodegradable network. In vitro, it showed biphasic levofloxacin release (~\u200950% over 25 h) and maintained high MSC viability. The drug-loaded hydrogel exhibited significantly larger antibacterial inhibition zones against S. aureus and S. epidermidis than the drug-free hydrogels. In vivo, all hydrogel-treated groups showed significantly lower oxidative stress index (OSI) values than the levofloxacin-drop control. Histological scoring and quantitative morphometry demonstrated that the HA-containing hydrogels improved epithelial integrity and reduced inflammation, while significant stromal-edema reduction was observed in the CH\u2013HA\u2013D group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The thermosensitive CH\u2013HA hydrogel provided sustained in vitro levofloxacin release and, in this rabbit corneal burn model, was associated with lower day-10 corneal oxidative stress and improved selected histologic repair indices versus levofloxacin eye drops. These findings support further pharmacokinetic and longer-term studies of this platform as a potential ocular drug-delivery system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable; this preclinical animal study was not registered in a clinical trial registry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-04796-8","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:34:44Z","timestamp":1776357284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thermosensitive in situ\u2013gelling chitosan\u2013hyaluronic acid hydrogel for sustained levofloxacin release and improved corneal wound healing in a rabbit corneal chemical-burn model"],"prefix":"10.1186","author":[{"given":"Mohamadreza","family":"Aghamirsalim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"4796_CR1","first-page":"11","volume-title":"Corneal Anatomy and Optics","author":"AM Abbey","year":"2024","unstructured":"Abbey AM, Yoo SH. Corneal anatomy and optics. In: Corneal Topography: CRC Press; 2024. p. 11\u20139."},{"key":"4796_CR2","doi-asserted-by":"crossref","unstructured":"Qie J, Wang Y, Huang J, He X, Ye Y, Yao K, et al. A Customized janus hydrogel with both anti-fibrosis and anti\u2010infection properties for suture\u2010free and care\u2010free corneal injury repair. Adv Funct Mater. 2025:e13261.","DOI":"10.1002\/adfm.202513261"},{"key":"4796_CR3","doi-asserted-by":"crossref","unstructured":"Khan S, Do CW, Ho EA. Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders. Drug Deliv Transl Res. 2024.","DOI":"10.1007\/s13346-024-01756-x"},{"key":"4796_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01977-0","volume":"22","author":"OL Lanier","year":"2021","unstructured":"Lanier OL, Manfre MG, Bailey C, Liu Z, Sparks Z, Kulkarni S, et al. Review of approaches for increasing ophthalmic bioavailability for eye drop formulations. AAPS PharmSciTech. 2021;22:1\u201316.","journal-title":"AAPS PharmSciTech"},{"issue":"26","key":"4796_CR5","doi-asserted-by":"crossref","first-page":"2302174","DOI":"10.1002\/advs.202302174","volume":"10","author":"CJ Yang","year":"2023","unstructured":"Yang CJ, Nguyen DD, Lai JY. Poly (l-Histidine)\u2010mediated on\u2010demand therapeutic delivery of roughened ceria nanocages for treatment of chemical eye injury. Adv Sci. 2023;10(26):2302174.","journal-title":"Adv Sci"},{"key":"4796_CR6","doi-asserted-by":"crossref","first-page":"146864","DOI":"10.1016\/j.cej.2023.146864","volume":"476","author":"T-Y Ger","year":"2023","unstructured":"Ger T-Y, Yang C-J, Ghosh S, Lai J-Y. Biofunctionalization of nanoceria with sperminated hyaluronan enhances drug delivery performance for corneal alkali burn therapy. Chem Eng J. 2023;476:146864.","journal-title":"Chem Eng J"},{"key":"4796_CR7","doi-asserted-by":"crossref","first-page":"123164","DOI":"10.1016\/j.carbpol.2024.123164","volume":"352","author":"T-Y Ger","year":"2025","unstructured":"Ger T-Y, Yang C-J, Bui HL, Lue SJ, Yao C-H, Lai J-Y. Alginate-functionalized nanoceria as ion-responsive eye drop formulation to treat corneal abrasion. Carbohydr Polym. 2025;352:123164.","journal-title":"Carbohydr Polym"},{"issue":"6","key":"4796_CR8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/21691401.2017.1368024","volume":"46","author":"M Zhu","year":"2018","unstructured":"Zhu M, Wang J, Li N. A novel thermo-sensitive hydrogel-based on poly (N-isopropylacrylamide)\/hyaluronic acid of ketoconazole for ophthalmic delivery. Artif Cells Nanomed Biotechnol. 2018;46(6):1282\u20137.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"4796_CR9","doi-asserted-by":"crossref","first-page":"e0172306","DOI":"10.1371\/journal.pone.0172306","volume":"12","author":"UK Kotreka","year":"2017","unstructured":"Kotreka UK, Davis VL, Adeyeye MC. Development of topical ophthalmic in situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts. PLoS ONE. 2017;12(2):e0172306.","journal-title":"PLoS ONE"},{"key":"4796_CR10","doi-asserted-by":"crossref","unstructured":"Pal P, Sambhakar S, Paliwal S. Revolutionizing ophthalmic care: a review of ocular hydrogels from pathologies to therapeutic applications. Curr Eye Res. 2024:1\u201317.","DOI":"10.1080\/02713683.2024.2396385"},{"issue":"24","key":"4796_CR11","doi-asserted-by":"crossref","first-page":"1900702","DOI":"10.1002\/adhm.201900702","volume":"8","author":"DD Nguyen","year":"2019","unstructured":"Nguyen DD, Luo LJ, Lai JY. Dendritic effects of injectable biodegradable thermogels on pharmacotherapy of inflammatory glaucoma-associated degradation of extracellular matrix. Adv Healthc Mater. 2019;8(24):1900702.","journal-title":"Adv Healthc Mater"},{"key":"4796_CR12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2019.11.038","volume":"317","author":"L-J Luo","year":"2020","unstructured":"Luo L-J, Nguyen DD, Lai J-Y. Benzoic acid derivative-modified chitosan-g-poly (N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration. J Controlled Release. 2020;317:246\u201358.","journal-title":"J Controlled Release"},{"key":"4796_CR13","doi-asserted-by":"crossref","first-page":"111095","DOI":"10.1016\/j.msec.2020.111095","volume":"115","author":"L-J Luo","year":"2020","unstructured":"Luo L-J, Nguyen DD, Lai J-Y. Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease. Mater Sci Engineering: C. 2020;115:111095.","journal-title":"Mater Sci Engineering: C"},{"key":"4796_CR14","doi-asserted-by":"crossref","first-page":"126190","DOI":"10.1016\/j.cej.2020.126190","volume":"402","author":"J-Y Lai","year":"2020","unstructured":"Lai J-Y, Luo L-J, Nguyen DD. Multifunctional glutathione-dependent hydrogel eye drops with enhanced drug bioavailability for glaucoma therapy. Chem Eng J. 2020;402:126190.","journal-title":"Chem Eng J"},{"issue":"2","key":"4796_CR15","first-page":"1442","volume":"15","author":"X Kong","year":"2018","unstructured":"Kong X, Xu W, Zhang C, Kong W. Chitosan temperature-sensitive gel loaded with drug microspheres has excellent effectiveness, biocompatibility and safety as an ophthalmic drug delivery system. Exp Ther Med. 2018;15(2):1442\u20138.","journal-title":"Exp Ther Med"},{"key":"4796_CR16","doi-asserted-by":"crossref","first-page":"118688","DOI":"10.1016\/j.ijpharm.2019.118688","volume":"570","author":"H Shi","year":"2019","unstructured":"Shi H, Wang Y, Bao Z, Lin D, Liu H, Yu A, et al. Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability. Int J Pharm. 2019;570:118688.","journal-title":"Int J Pharm"},{"issue":"30","key":"4796_CR17","doi-asserted-by":"crossref","first-page":"2006335","DOI":"10.1002\/smll.202006335","volume":"17","author":"S Khosravimelal","year":"2021","unstructured":"Khosravimelal S, Mobaraki M, Eftekhari S, Ahearne M, Seifalian AM, Gholipourmalekabadi M. Hydrogels as emerging materials for cornea wound healing. Small. 2021;17(30):2006335.","journal-title":"Small"},{"issue":"9","key":"4796_CR18","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1016\/j.actbio.2009.05.012","volume":"5","author":"W Thein-Han","year":"2009","unstructured":"Thein-Han W, Saikhun J, Pholpramoo C, Misra R, Kitiyanant Y. Chitosan\u2013gelatin scaffolds for tissue engineering: Physico-chemical properties and biological response of buffalo embryonic stem cells and transfectant of GFP\u2013buffalo embryonic stem cells. Acta Biomater. 2009;5(9):3453\u201366.","journal-title":"Acta Biomater"},{"key":"4796_CR19","doi-asserted-by":"crossref","first-page":"119961","DOI":"10.1016\/j.biomaterials.2020.119961","volume":"243","author":"L-J Luo","year":"2020","unstructured":"Luo L-J, Nguyen DD, Lai J-Y. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy. Biomaterials. 2020;243:119961.","journal-title":"Biomaterials"},{"issue":"11","key":"4796_CR20","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.7150\/thno.54525","volume":"11","author":"L-J Luo","year":"2021","unstructured":"Luo L-J, Nguyen DD, Lai J-Y. Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. Theranostics. 2021;11(11):5447.","journal-title":"Theranostics"},{"key":"4796_CR21","doi-asserted-by":"crossref","first-page":"100183","DOI":"10.1016\/j.mtbio.2021.100183","volume":"13","author":"DD Nguyen","year":"2021","unstructured":"Nguyen DD, Luo L-J, Lai J-Y. Thermogels containing sulfated hyaluronan as novel topical therapeutics for treatment of ocular surface inflammation. Mater Today Bio. 2021;13:100183.","journal-title":"Mater Today Bio"},{"key":"4796_CR22","doi-asserted-by":"crossref","first-page":"132409","DOI":"10.1016\/j.cej.2021.132409","volume":"429","author":"L-J Luo","year":"2022","unstructured":"Luo L-J, Nguyen DD, Huang C-C, Lai J-Y. Therapeutic hydrogel sheets programmed with multistage drug delivery for effective treatment of corneal abrasion. Chem Eng J. 2022;429:132409.","journal-title":"Chem Eng J"},{"issue":"2","key":"4796_CR23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10971-022-06020-7","volume":"105","author":"NHN Do","year":"2023","unstructured":"Do NHN, Pham TH, Le PK, Ha AC. Thermo-responsive Chitosan\/\u03b2-glycerophosphate hydrogels directly post-loading anti-inflammatory diclofenac sodium. J Solgel Sci Technol. 2023;105(2):451\u201360.","journal-title":"J Solgel Sci Technol"},{"issue":"12","key":"4796_CR24","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/pharmaceutics12121232","volume":"12","author":"M Mobaraki","year":"2020","unstructured":"Mobaraki M, Soltani M, Zare Harofte S, Zoudani L, Daliri E, Aghamirsalim R. Biodegradable nanoparticle for cornea drug delivery: Focus review. Pharmaceutics. 2020;12(12):1232.","journal-title":"Pharmaceutics"},{"issue":"5","key":"4796_CR25","first-page":"482","volume":"24","author":"M Accorinti","year":"2016","unstructured":"Accorinti M, Colao L, Gilardi M, Cecere M, Salotti A, Pesci FR. Levofloxacin and tobramycin for severe bacterial keratouveitis. Ocul Immunol Inflamm. 2016;24(5):482\u20138.","journal-title":"Ocul Immunol Inflamm"},{"key":"4796_CR26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2165\/00003495-200969090-00009","volume":"69","author":"GM Keating","year":"2009","unstructured":"Keating GM. Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery. Drugs. 2009;69:1267\u201386.","journal-title":"Drugs"},{"issue":"1","key":"4796_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jbm.b.34359","volume":"108","author":"YH Cheng","year":"2020","unstructured":"Cheng YH, Chang YF, Ko YC, Liu CJ. Sustained release of levofloxacin from thermosensitive chitosan-based hydrogel for the treatment of postoperative endophthalmitis. J Biomed Mater Res B Appl Biomater. 2020;108(1):8\u201313.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"6","key":"4796_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10965-019-1771-z","volume":"26","author":"P Patel","year":"2019","unstructured":"Patel P, Mandal A, Gote V, Pal D, Mitra AK. Thermosensitive hydrogel-based drug delivery system for sustained drug release. J Polym Res. 2019;26(6):131.","journal-title":"J Polym Res"},{"key":"4796_CR29","doi-asserted-by":"crossref","unstructured":"Bucci FA Jr, Nguimfack IT, Fluet AT. Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery. Clin Ophthalmol. 2016:783\u20139.","DOI":"10.2147\/OPTH.S91286"},{"issue":"01","key":"4796_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.17925\/EOR.2009.02.01.12","volume":"02","author":"M Kresken","year":"2009","unstructured":"Kresken M. Effectiveness of levofloxacin eye drops\u2013A microbiological perspective. Eur Ophthalmic Rev. 2009;02(01):12.","journal-title":"Eur Ophthalmic Rev"},{"issue":"5","key":"4796_CR31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/eye.2009.179","volume":"24","author":"T Tsai","year":"2010","unstructured":"Tsai T, Chen W, Hu F. Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells. Eye. 2010;24(5):909\u201317.","journal-title":"Eye"},{"issue":"11","key":"4796_CR32","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.biomaterials.2005.11.015","volume":"27","author":"D Gupta","year":"2006","unstructured":"Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials. 2006;27(11):2370\u20139.","journal-title":"Biomaterials"},{"key":"4796_CR33","unstructured":"Badertscher M, B\u00fchlmann P, Pretsch E. Structure determination of organic compounds. Tables of spectral data. Berlin: Springer; 2009."},{"key":"4796_CR34","unstructured":"ISO P. 10993-5. 2009; Biological evaluation of medical devices\u2014Part 5: in vitro cytotoxicity tests. International Organization for Standarization: Geneva, Switzerland. 2009."},{"key":"4796_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2024.05.031","volume":"371","author":"B Ahmed","year":"2024","unstructured":"Ahmed B, Jaiswal S, Naryal S, Shah RM, Alany RG, Kaur IP. In situ gelling systems for ocular drug delivery. J Controlled Release. 2024;371:67\u201384.","journal-title":"J Controlled Release"},{"issue":"4","key":"4796_CR36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.drudis.2013.10.001","volume":"19","author":"H Almeida","year":"2014","unstructured":"Almeida H, Amaral MH, Lob\u00e3o P, Lobo JM. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today. 2014;19(4):400\u201312.","journal-title":"Drug Discov Today"},{"key":"4796_CR37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.carbpol.2014.09.094","volume":"117","author":"HY Zhou","year":"2015","unstructured":"Zhou HY, Jiang LJ, Cao PP, Li JB, Chen XG. Glycerophosphate-based chitosan thermosensitive hydrogels and their biomedical applications. Carbohydr Polym. 2015;117:524\u201336.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"4796_CR38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/08853282211024164","volume":"36","author":"T Vieira de Souza","year":"2021","unstructured":"Vieira de Souza T, Malmonge SM, Santos AR. Jr. Development of a chitosan and hyaluronic acid hydrogel with potential for bioprinting utilization: A preliminary study. J Biomater Appl. 2021;36(2):358\u201371.","journal-title":"J Biomater Appl"},{"key":"4796_CR39","doi-asserted-by":"publisher","unstructured":"Aghamirsalim M, Mobaraki M, Jabbarvand M, Sahraian A. Thermosensitive chitosan-hyaluronic acid hydrogel for sustained betamethasone and levofloxacin delivery in corneal wound healing. Transl Vis Sci Technol. 2026;15(3):2. https:\/\/doi.org\/10.1167\/tvst.15.3.2.","DOI":"10.1167\/tvst.15.3.2"},{"key":"4796_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.carbpol.2015.08.098","volume":"135","author":"C-Y Tsai","year":"2016","unstructured":"Tsai C-Y, Woung L-C, Yen J-C, Tseng P-C, Chiou S-H, Sung Y-J, et al. Thermosensitive chitosan-based hydrogels for sustained release of ferulic acid on corneal wound healing. Carbohydr Polym. 2016;135:308\u201315.","journal-title":"Carbohydr Polym"},{"key":"4796_CR41","doi-asserted-by":"crossref","first-page":"135301","DOI":"10.1016\/j.ijbiomac.2024.135301","volume":"279","author":"Y Lan","year":"2024","unstructured":"Lan Y, Wang Y, Qi X, Cai E, Xiang Y, Ge X, et al. A modified hyaluronic acid hydrogel with strong bacterial capture and killing capabilities for drug-resistant bacteria-infected diabetic wound healing. Int J Biol Macromol. 2024;279:135301.","journal-title":"Int J Biol Macromol"},{"key":"4796_CR42","doi-asserted-by":"crossref","first-page":"100565","DOI":"10.1016\/j.mtadv.2025.100565","volume":"25","author":"A Durand","year":"2025","unstructured":"Durand A, Gr\u00e9a T, Lebeau G, Jacquot G, Tillement A, Aigle A, et al. Functionalization of chitosan with a polycarboxylic macrocycle yields injectable hydrogel with pH and salts responsiveness. Mater Today Adv. 2025;25:100565.","journal-title":"Mater Today Adv"},{"issue":"6","key":"4796_CR43","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/jop.2021.0127","volume":"38","author":"HK Polat","year":"2022","unstructured":"Polat HK, Kurt N, Aytekin E, Bozda\u011f Pehlivan S, \u00c7al\u0131\u015f S. Novel Drug Delivery Systems to Improve the Treatment of Keratitis. J Ocul Pharmacol Ther. 2022;38(6):376\u201395.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"4796_CR44","doi-asserted-by":"crossref","first-page":"e001093","DOI":"10.1136\/bmjophth-2022-001093","volume":"7","author":"LRDR Ponniah","year":"2022","unstructured":"Ponniah LRDR, Ranilakshmi V, Anandan H, Caroline J, Arulanandham A. Novel drug-repository contact lens for prolonging the antimicrobial-cornea interaction for bacterial keratitis treatment: randomised controlled trial results. BMJ Open Ophthalmol. 2022;7(1):e001093.","journal-title":"BMJ Open Ophthalmol"},{"key":"4796_CR45","doi-asserted-by":"crossref","first-page":"137479","DOI":"10.1016\/j.ijbiomac.2024.137479","volume":"283","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wang A, Qin Y, Chen X, Feng X, He G, et al. Preparation of a thermosensitive and antibacterial in situ gel using poloxamer-quaternized chitosan for sustained ocular delivery of levofloxacin hydrochloride. Int J Biol Macromol. 2024;283:137479.","journal-title":"Int J Biol Macromol"},{"key":"4796_CR46","first-page":"100201","volume":"6","author":"OA Agha","year":"2023","unstructured":"Agha OA, Girgis GN, El-Sokkary MM, Soliman OAE-A. Spanlastic-laden in situ gel as a promising approach for ocular delivery of levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study. Int J Pharmaceutics: X. 2023;6:100201.","journal-title":"Int J Pharmaceutics: X"},{"issue":"7","key":"4796_CR47","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/polym12071519","volume":"12","author":"A Zamboulis","year":"2020","unstructured":"Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, et al. Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments. Polymers. 2020;12(7):1519.","journal-title":"Polymers"},{"key":"4796_CR48","doi-asserted-by":"crossref","first-page":"123018","DOI":"10.1016\/j.carbpol.2024.123018","volume":"349","author":"D Fern\u00e1ndez-Villa","year":"2025","unstructured":"Fern\u00e1ndez-Villa D, Herraiz A, de Wit K, Herranz F, Aguilar MR, Rojo L. Design of tunable hyaluronic acid and O\u2032-carboxymethyl chitosan formulations for the minimally invasive delivery of multifunctional therapies targeting rheumatoid arthritis. Carbohydr Polym. 2025;349:123018.","journal-title":"Carbohydr Polym"},{"key":"4796_CR49","doi-asserted-by":"crossref","first-page":"107141","DOI":"10.1016\/j.bpc.2023.107141","volume":"305","author":"M Rostamipoor","year":"2024","unstructured":"Rostamipoor M, Farsinejad A, Amiri M, Fatemi A, Khazaeli P, Anvari S. Topical ocular administration using thermosensitive chitosan-glycerophosphate-PRP hydrogels for improved ocular bioavailability. Biophys Chem. 2024;305:107141.","journal-title":"Biophys Chem"},{"key":"4796_CR50","doi-asserted-by":"crossref","first-page":"104385","DOI":"10.1016\/j.jddst.2023.104385","volume":"83","author":"M Ghanavi","year":"2023","unstructured":"Ghanavi M, Khoshandam A, Aslzad S, Fathi M, Barzegari A, Abdolahinia ED, et al. Injectable thermosensitive PEG-g-chitosan hydrogel for ocular delivery of vancomycin and prednisolone. J Drug Deliv Sci Technol. 2023;83:104385.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"10","key":"4796_CR51","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.ophtha.2011.03.017","volume":"118","author":"SB Dave","year":"2011","unstructured":"Dave SB, Toma HS, Kim SJ. Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology. 2011;118(10):2035\u201340.","journal-title":"Ophthalmology"},{"issue":"3","key":"4796_CR52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/microorganisms13030670","volume":"13","author":"Q Shi","year":"2025","unstructured":"Shi Q, Mao D, Zhang Z, Qudsi AI, Wei M, Cheng Z, et al. Epidemiological and antimicrobial resistance trends in bacterial keratitis: a hospital-based 10-year study (2014\u20132024). Microorganisms. 2025;13(3):670.","journal-title":"Microorganisms"},{"issue":"1","key":"4796_CR53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pathogens7010009","volume":"7","author":"RJ O\u2019Callaghan","year":"2018","unstructured":"O\u2019Callaghan RJ. The pathogenesis of Staphylococcus aureus eye infections. Pathogens. 2018;7(1):9.","journal-title":"Pathogens"},{"issue":"192","key":"4796_CR54","doi-asserted-by":"crossref","first-page":"ra19285","DOI":"10.1126\/scitranslmed.3006055","volume":"5","author":"S Kalghatgi","year":"2013","unstructured":"Kalghatgi S, Spina CS, Costello JC, Liesa M, Morones-Ramirez JR, Slomovic S, et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells. Sci Transl Med. 2013;5(192):ra19285\u201385.","journal-title":"Sci Transl Med"},{"issue":"8","key":"4796_CR55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/antiox7080098","volume":"7","author":"M Cano Sanchez","year":"2018","unstructured":"Cano Sanchez M, Lancel S, Boulanger E, Neviere R. Targeting oxidative stress and mitochondrial dysfunction in the treatment of impaired wound healing: a systematic review. Antioxidants. 2018;7(8):98.","journal-title":"Antioxidants"},{"key":"4796_CR56","doi-asserted-by":"crossref","first-page":"100320","DOI":"10.1016\/j.medntd.2024.100320","volume":"23","author":"L Shang","year":"2024","unstructured":"Shang L, Li M, Xu A, Zhuo F. Recent applications and molecular mechanisms of hyaluronic acid in skin aging and wound healing. Med Novel Technol Devices. 2024;23:100320.","journal-title":"Med Novel Technol Devices"},{"key":"4796_CR57","doi-asserted-by":"crossref","unstructured":"Parmal S, Subbappa P, Nikam V, Tarwate Y, Barhate K, Wagh S, et al. Hyaluronic acid based approaches for wound healing: a comprehensive review. Int J Biol Macromol. 2025:141625.","DOI":"10.1016\/j.ijbiomac.2025.141625"},{"issue":"1","key":"4796_CR58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41536-024-00385-9","volume":"10","author":"F Chen","year":"2025","unstructured":"Chen F, Han U, Wungcharoen T, Seo YA, Le P, Jiang L, et al. Bio-orthogonal crosslinking and hyaluronan facilitate transparent healing after treatment of deep corneal injuries with in situ-forming hydrogels. NPJ Regen Med. 2025;10(1):8.","journal-title":"npj Regenerative Med"},{"key":"4796_CR59","doi-asserted-by":"crossref","first-page":"e0060","DOI":"10.37039\/1982.8551.20250060","volume":"84","author":"G Saldana","year":"2025","unstructured":"Saldana G, Martinez D, Verma S, Coulson-Thomas VJ. Clinical use of topical hyaluronan for promoting corneal wound healing: a systematic review. Revista Brasileira de Oftalmologia. 2025;84:e0060.","journal-title":"Revista Brasileira de Oftalmologia"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04796-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:13:49Z","timestamp":1781648029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04796-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":59,"alternative-id":["4796"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04796-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Ethics Committee of the Translational Ophthalmology Research Center, Tehran University of Medical Sciences (protocol code IR.TUMS.FARABIH.REC.1399.001, approved in 2020), and all procedures adhered to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The study did not involve human participants, human data or human tissue; therefore, consent to participate is not applicable. The rabbits were laboratory-bred animals obtained from the university\u2019s dedicated animal research facility; therefore, owner consent is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (including images, videos or case details).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MRA, RF and AS are affiliated with the Translational Ophthalmology Research Center, Tehran University of Medical Sciences, Tehran, Iran. MAb is affiliated with Zhino-Gene Research Service Co., Tehran, Iran.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author information"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}